Patents by Inventor Chun Won Kim

Chun Won Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240134292
    Abstract: A substrate treatment apparatus according to an aspect of the present invention includes: a support plate that supports a substrate and is provided with a heater member for heating the substrate; and a cooling unit for forcedly cooling the support plate, wherein the cooling unit includes: a cooling housing to provide a cooling space; a plurality of gas feed nozzles that is arranged in the cooling housing and supplies cooling gas toward the heater member; and a plurality of gas feed lines that is directly connected to the gas feed nozzles and supplies the cooling gas transferred from the outside to the gas feed nozzles.
    Type: Application
    Filed: October 4, 2023
    Publication date: April 25, 2024
    Applicant: SEMES CO., LTD.
    Inventors: Minhee CHO, Hee Man AHN, Gyeong Won SONG, Jumi LEE, Chun Woo PARK, Byung Hwi KIM
  • Patent number: 5891864
    Abstract: The present invention relates to an anti-cancer composition containing acridine derivatives and guanosine compounds. In the composition of the present invention, the acridine derivative and the guanosine compound are present in the weight ratio of 1:0.1-5.0, preferably 1:0.3-3.0 and more preferably 1:0.5-1.5. In the composition of the present invention, most preferably the acridine derivative is acriflavine neutral and the guanosine compound is guanosine hydrate. Although acridine derivatives and guanosine compounds used as an active ingredient in the present composition have substantially no anti-cancer effect when they are used individually, the combination of acriflavine neutral and guanosine hydrate which potentiates the effect of acriflavine neutral, i.e. the composition(AG60) according to the present invention, exhibits reduced toxicity and increased anti-cancer effect in comparison to the use of acriflavine neutral or guanosine hydrate alone.
    Type: Grant
    Filed: November 3, 1995
    Date of Patent: April 6, 1999
    Assignees: Yung Bok Han, Tae Rim Pharm. Co., Ltd.
    Inventors: Yung Bok Han, Hong Ki Kyung, Chun Won Kim, E Tay Ahn, Jong Bae Kim, Hyo Suk Lee, Kyung Yung Lee, Eun Kyung Hong, Hee Sook Choi, Sang Geon Kim, Bo Im Yoo, Hae Kyung Kwon